CABERGOLINE Side Effects

7021231-0 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 37 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dopamine dysregulation syndrome. Cabergoline dosage: 2 Mg, Day. During the same period patient was treated with LEVODOPA (300 Mg, Day) (View Levodopa Review and Levodopa Label ), ROTIGOTINE (4 Mg, Day) (View Rotigotine Review and Rotigotine Label ), BENZATROPINE (Unk) (View Benzatropine Review and Benzatropine Label ), TRIHEXYPHENIDYL (10 Mg, Day) (View Trihexyphenidyl Review and Trihexyphenidyl Label ).

7021230-9 | Dopamine Dysregulation Syndrome
Patient was taking Cabergoline (View Usage). Patient had the following side effects: dopamine dysregulation syndrome on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with on and off phenomenon, parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: Unk. During the same period patient was treated with ENTACAPONE (Unk) (View Entacapone Review and Entacapone Label ), LEVODOPA (300 Mg, Day) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3.5 Mg, Day) (View Pergolide Review and Pergolide Label ), ROPINIROLE (Unk) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.

7021228-0 | Dopamine Dysregulation Syndrome, On And Off Phenomenon, Paranoia
Adverse event was reported on Sep 15, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 3 Mg, Day) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 50 years of age, After Cabergoline was administered, patient had the following side effects: dopamine dysregulation syndrome, on and off phenomenon, paranoia. During the same period patient was treated with AMANTADINE (100 Mg, Day) (View Amantadine Review and Amantadine Label ), LEVODOPA (500 Mg, Day) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 Mg, Day) (View Pergolide Review and Pergolide Label ). Patient was hospitalized.

7016837-9 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dopamine dysregulation syndrome. Cabergoline dosage: 6 Mg, Daily. During the same period patient was treated with AMANTADINE (100 Mg, Daily) (View Amantadine Review and Amantadine Label ), LEVODOPA (500 Mg, Daily) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 Mg, Daily) (View Pergolide Review and Pergolide Label ). Patient was hospitalized.


7016836-7 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 37 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: dopamine dysregulation syndrome. Cabergoline dosage: 8 Mg, Daily, Self-medicated. During the same period patient was treated with L DOPA (300 Mg, Daily) (View L-dopa Review and L-dopa Label ), ROTIGOTINE (4 Mg, Daily) (View Rotigotine Review and Rotigotine Label ), BENZTROPINE MESYLATE (4 Mg, Daily) (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

7016834-3 | Dopamine Dysregulation Syndrome, Intentional Self-injury
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: dopamine dysregulation syndrome, intentional self-injury on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with on and off phenomenon, parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: Up To 4 Mg/day. During the same period patient was treated with ENTACAPONE (Unk) (View Entacapone Review and Entacapone Label ), LEVODOPA (1200 Mg, Daily, Self-administered) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 1/2 Mg, Daily) (View Pergolide Review and Pergolide Label ), ROPINIROLE (Up To 32 Mg, Daily, Self-administered) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.

7008856-3 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Sep 09, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: Unk) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 55 years of age, Patient experienced the following unwanted or unexpected effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea.

7008855-1 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from UNITED KINGDOM , 39 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (Unk) (View Bromocriptine Review and Bromocriptine Label ).

7008854-X | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from UNITED KINGDOM , 36 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (Unk) (View Bromocriptine Review and Bromocriptine Label ).

7008853-8 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 46 years of age, was diagnosed with prolactinoma and. Cabergoline dosage: Unk.

7008852-6 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Sep 09, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg, Three Days A Week For 2 Months) was diagnosed with prolactinoma and. Location: ITALY , 39 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea. Patient was hospitalized.

7008851-4 | Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from ITALY , 53 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.5 Mg, Twice A Week. Patient was hospitalized.

7008850-2 | Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from ITALY , 42 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.5 Mg, 6 Days In A Week For 2 Months. Patient was hospitalized.

7006338-6 | Fatigue, Leukopenia
Patient was taking Cabergoline (View Usage). Patient had the following side effects: fatigue, leukopenia on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, weighting 173.1 lb, was diagnosed with prolactinoma and. Cabergoline dosage: 500 Mcg, 1/week. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6984552-3 | Fatigue, Leukopenia
Adverse event was reported on Sep 08, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 500 Ug, Weekly) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 73 years of age, weighting 173.1 lb, After Cabergoline was administered, patient had the following side effects: fatigue, leukopenia. During the same period patient was treated with AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (Unk) (View Atorvastatin Review and Atorvastatin Label ), EZETIMIBE (Unk) (View Ezetimibe Review and Ezetimibe Label ), RABEPRAZOLE (Unk) (View Rabeprazole Review and Rabeprazole Label ).

6981049-1 | Fatigue, Leukopenia
on Sep 08, 2010 Male patient from UNITED KINGDOM , 73 years of age, weighting 173.1 lb, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, leukopenia. Cabergoline dosage: .

6980086-0 | Blood Albumin Decreased, Blood Bilirubin Decreased, Blood Chloride Increased, Blood Cortisol Decreased, Blood Creatinine Increased, Blood Gastrin Increased, Blood Glucose Decreased, Blood Sodium Decreased, Blood Urea Increased
on Aug 31, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: blood albumin decreased, blood bilirubin decreased, blood chloride increased, blood cortisol decreased, blood creatinine increased, blood gastrin increased, blood glucose decreased, blood sodium decreased, blood urea increased. Cabergoline dosage: 0.5 Mg, Twice A Week. During the same period patient was treated with LEVOTHYROXINE SODIUM (50 Mcg, Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6964743-8 | Cerebrospinal Fluid Rhinorrhoea, Pneumocephalus
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea, pneumocephalus on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with multiple endocrine adenomatosis type i, prolactinoma and. Cabergoline dosage: 0.5 Mg, 2x/week. During the same period patient was treated with LEVOTHYROXINE (50 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ).

6882887-6 | Bronchospasm
Adverse event was reported on Jan 12, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg, Unk) was diagnosed with pituitary tumour, thyroid disorder, headache (What is headache?) and. Location: COLOMBIA , 54 years of age, Patient experienced the following unwanted or unexpected effects: bronchospasm. During the same period patient was treated with LEVOTHYROXINE (50 Mg, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), ACETAMINOPHEN (50 Mg, 1x/day) (View Acetaminophen Review and Acetaminophen Label ).

6877168-0 | Priapism
on Jul 15, 2010 Male patient from SPAIN , 33 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: priapism. Cabergoline dosage: Unk. Patient was hospitalized.

6871308-5 | Aortic Valve Incompetence, Cardiac Valve Disease, Cerebrovascular Accident, Depression Suicidal, Divorced, Dyspnoea, Fluid Retention, Hepatic Cirrhosis, Hepatic Steatosis
on Jul 13, 2010 Male patient from GERMANY , 57 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: aortic valve incompetence, cardiac valve disease, cerebrovascular accident, depression suicidal, divorced, dyspnoea, fluid retention, hepatic cirrhosis, hepatic steatosis. Cabergoline dosage: 4 Mg, 1x/day. During the same period patient was treated with ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), SIMVASTATIN (20 Mg, 2x/day) (View Simvastatin Review and Simvastatin Label ), TOREM (10 Mg, 2x/day) (View Torem Review and Torem Label ), ALLOPURINOL (200 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), PANTOZOL (40 Mg, 1x/day) (View Pantozol Review and Pantozol Label ), FERRO SANOL (20 Gtt, 1x/day) (View Ferro Sanol Review and Ferro Sanol Label ), DELIX PLUS (1 Df, 1x/day) (View Delix Plus Review and Delix Plus Label ), MADOPAR (50 Mg, 3x/day) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6863804-1 | Caesarean Section, Complication Of Delivery
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, complication of delivery on Jul 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and. Cabergoline dosage: Unk. Patient was hospitalized.

6847485-9 | Cardiac Valve Disease, Depression, Dyspnoea, Fluid Retention, Impulse-control Disorder, Pathological Gambling, Suicide Attempt
Adverse event was reported on Jul 07, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 2 Mg, 1x/day) was diagnosed with restless legs syndrome and. Location: GERMANY , 57 years of age, Patient had the following side effects: cardiac valve disease, depression (What is depression?), dyspnoea, fluid retention, impulse-control disorder, pathological gambling, suicide attempt. During the same period patient was treated with CHOLESTEROL (View Cholesterol Review and Cholesterol Label ).

6839144-3 | Caesarean Section
on Jul 09, 2010 Female patient from UNITED KINGDOM , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: caesarean section. Cabergoline dosage: .

6817796-1 | Caesarean Section
on Jun 23, 2010 Female patient from UNITED KINGDOM , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section. Cabergoline dosage: Unk.

6804119-7 | Blood Prolactin Increased, Fatigue, Insomnia, Mood Altered, Weight Decreased
Patient was taking Cabergoline (View Usage). Patient had the following side effects: blood prolactin increased, fatigue, insomnia, mood altered, weight decreased on Mar 02, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with pituitary tumour benign and. Cabergoline dosage: 2 Every 1 Weeks. During the same period patient was treated with DOSTINEX (2 Every 1 Weeks) (View Dostinex Review and Dostinex Label ).

6804095-7 | Headache, Insomnia, Malaise, Nausea, Psychomotor Hyperactivity
Adverse event was reported on Dec 26, 2006 by a Female patient taking Cabergoline (View Usage) (Dosage: 2 Every 1 Weeks) was diagnosed with pituitary tumour benign, hyperprolactinaemia, thyroid disorder and. Location: UNITED STATES , weighting 159.0 lb, After Cabergoline was administered, patient had the following side effects: headache (What is headache?), insomnia, malaise, nausea (What is nausea?), psychomotor hyperactivity. During the same period patient was treated with DOSTINEX (2 Every 1 Weeks) (View Dostinex Review and Dostinex Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

6775382-6 | Neoplasm Progression
on Jun 08, 2010 Male patient from ARGENTINA , 70 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm progression. Cabergoline dosage: 1 Mg, Weekly.

6738726-7 | Cerebrospinal Fluid Rhinorrhoea
on May 13, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with prolactin-producing pituitary tumour and was treated with Cabergoline (View Usage). Patient had the following side effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.25 Mg, Weekly.

6733017-2 | Abnormal Behaviour, Aortic Valve Calcification, Blood Albumin Decreased, Blood Glucose Increased, Disorientation, Dyspnoea, Gait Disturbance, Lung Disorder
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: abnormal behaviour, aortic valve calcification, blood albumin decreased, blood glucose increased, disorientation, dyspnoea, gait disturbance, lung disorder on Apr 30, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 3 Mg Daily. Patient was hospitalized.

6731753-5 | Retroperitoneal Fibrosis
Adverse event was reported on May 10, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 To 1.0 Mg Per Day) was diagnosed with hypophysitis, hyperprolactinaemia, galactorrhoea and. Location: JAPAN , 45 years of age, Patient experienced the following unwanted or unexpected effects: retroperitoneal fibrosis.

6712022-6 | Oestradiol Increased
on Apr 23, 2010 Female patient from JAPAN , 47 years of age, was treated with Cabergoline (View Usage). Patient had the following side effects: oestradiol increased. Cabergoline dosage: .

6707942-2 | Dystonia, Gastrointestinal Disorder, Incorrect Dose Administered, Torticollis
on Apr 13, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: dystonia (What is dystonia?), gastrointestinal disorder, incorrect dose administered, torticollis. Cabergoline dosage: 1 Mg, Tid; 0.25 Mg, Tid. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLO (BENSERAZIDE HYDROCHLORIDE, LEVODOPA) (View Levodopa Benserazide Hydrochlo (benserazide Hydrochloride, Levodopa) Review and Levodopa Benserazide Hydrochlo (benserazide Hydrochloride, Levodopa) Label ).

6707588-6 | Akinesia, Posture Abnormal, Torticollis
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: akinesia, posture abnormal, torticollis on Apr 13, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: .

6704142-7 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Apr 21, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.25 Mg, Weekly) was diagnosed with prolactin-producing pituitary tumour and. Location: JAPAN , 40 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea.

6703988-9 | Disease Progression, Lung Disorder, Pleural Effusion
on Apr 17, 2010 Male patient from UNITED KINGDOM , 57 years of age, was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: disease progression, lung disorder, pleural effusion. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (30 Mg, Daily) (View Bromocriptine Review and Bromocriptine Label ).

6703987-7 | Interstitial Lung Disease
on Apr 17, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Cabergoline dosage: 1 Mg, Daily. Patient was hospitalized.

6699082-6 | Atelectasis, Dyspnoea, Pleural Effusion, Pleuritic Pain, Pulmonary Fibrosis
Patient was taking Cabergoline (View Usage). Patient had the following side effects: atelectasis, dyspnoea, pleural effusion, pleuritic pain, pulmonary fibrosis (What is pulmonary fibrosis?) on Apr 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 62 years of age, . Cabergoline dosage: 10 Mg, Daily. Patient was hospitalized.

6693284-0 | Antiphospholipid Antibodies Positive, Arthralgia, Dyspnoea, Mixed Connective Tissue Disease, Pulmonary Hypertension, Raynaud's Phenomenon
Adverse event was reported on Apr 21, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg Twice A Week Po) was diagnosed with prolactinoma and. Location: UNITED STATES , weighting 143.0 lb, After Cabergoline was administered, patient had the following side effects: antiphospholipid antibodies positive, arthralgia, dyspnoea, mixed connective tissue disease, pulmonary hypertension (What is pulmonary hypertension?), raynaud's phenomenon.

6689975-8 | Hip Arthroplasty
on Jan 25, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: hip arthroplasty. Cabergoline dosage: 1 Mg, 1x/day. Patient was hospitalized.

6681878-8 | Torticollis
on Mar 26, 2010 Male patient from JAPAN , 80 years of age, was treated with Cabergoline (View Usage). Patient had the following side effects: torticollis. Cabergoline dosage: 3 Mg. During the same period patient was treated with CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ).

6681869-7 | Torticollis
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: torticollis on Mar 26, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: .

6681671-6 | Condition Aggravated, Parkinson's Disease, Torticollis
Adverse event was reported on Mar 26, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 3 Mg, Qd) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, parkinson's disease (What is parkinson's disease?), torticollis. During the same period patient was treated with PRAMIPEXOL DIHYDROCHLORIDE (MIRAPEX) (2 Mg, Qd ; 1 Mg, Qd) (View Pramipexol Dihydrochloride (mirapex) Review and Pramipexol Dihydrochloride (mirapex) Label ), CARBIDOPA + LEVODOPA (50 Mg, Qd) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ). Patient was hospitalized.

6679318-8 | Aortic Valve Incompetence, Cardiac Failure, Mitral Valve Incompetence
on Mar 25, 2010 Male patient from ITALY , 72 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: . Patient was hospitalized.

6678640-9 | Retroperitoneal Fibrosis
on Mar 31, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with hypophysitis, hyperprolactinaemia, galactorrhoea and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: retroperitoneal fibrosis. Cabergoline dosage: .

6674401-5 | Dizziness, Feeling Abnormal, Oedema Peripheral, Visual Impairment
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), feeling abnormal, oedema peripheral, visual impairment on Mar 29, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, weighting 151.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 2 Mg, 2x/day.

6668293-8 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Mar 24, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.25 Mg, Weekly) was diagnosed with prolactin-producing pituitary tumour and. Location: JAPAN , 40 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea.

6668291-4 | Cerebrospinal Fluid Rhinorrhoea, Meningitis Bacterial
on Mar 24, 2010 Male patient from JAPAN , 41 years of age, was diagnosed with pituitary tumour benign and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea, meningitis bacterial. Cabergoline dosage: .

6659923-5 | C-reactive Protein Increased, Lymphocyte Stimulation Test Positive, Oedema, Pleural Effusion
on Mar 11, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, lymphocyte stimulation test positive, oedema, pleural effusion. Cabergoline dosage: 3 Mg Daily.

6656484-1 | Aggression, Hypersexuality, Libido Increased, Masked Facies, Pathological Gambling, Psychomotor Skills Impaired, Tremor
Patient was taking Cabergoline (View Usage). Patient had the following side effects: aggression, hypersexuality, libido increased, masked facies, pathological gambling, psychomotor skills impaired, tremor on Mar 17, 2010 from GERMANY Additional patient health information: Male patient , 35 years of age, weighting 172.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 4mg/day. During the same period patient was treated with TREMARIT (Unk) (View Tremarit Review and Tremarit Label ), CIALIS (10 Mg, Unk) (View Cialis Review and Cialis Label ).